Literature DB >> 19127954

Optimal drug therapy for children: Canadian initiatives.

Michael Rieder1.   

Abstract

Canada has a long tradition of undertaking research and training in pediatric clinical pharmacology, and has one of the longest continuous enterprises in this field in the world. Training in pediatric clinical pharmacology in Canada is nationally accredited and rigorous. Canada has the largest number of pediatric clinical pharmacologists per capita of any country on earth, but to date there have been no federally supported initiatives for child-focused drug research. The recent development of a unique national network focused on drug safety - the Genotypic Approaches to Therapy in Children - has provided a framework that it hopes will facilitate networking as well as the development of coordinated national and hopefully international initiatives in pediatric therapeutics.

Entities:  

Mesh:

Year:  2009        PMID: 19127954     DOI: 10.2165/0148581-200911010-00016

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  4 in total

Review 1.  Clinical pharmacology education: looking into the future.

Authors:  J D Gray; D Danoff; A M Shepherd
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

2.  Critical appraisal rounds: a new training model for clinical pharmacologists.

Authors:  Gideon Koren; Irena Nulman
Journal:  Can J Clin Pharmacol       Date:  2007-03-14

3.  The network of pediatric pharmacology training programs.

Authors:  G Koren; M Kriska; G Pons; N Shear; E Sanz; S MacLeod
Journal:  Clin Pharmacol Ther       Date:  1993-07       Impact factor: 6.875

4.  Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

Authors:  Colin J D Ross; Bruce Carleton; Dana G Warn; Sunita B Stenton; Shahrad Rod Rassekh; Michael R Hayden
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.